OptimizeRx OPRX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $6.84M+144% | $5.13M+126% | $34K+100% | -$9.87M+44.9% | -$15.41M+14.7% | ||
| $18.5M— | $16.03M— | —— | —— | —— | ||
| $14.2M— | $11.71M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is OptimizeRx's revenue?
- OptimizeRx (OPRX) generated $107.3M in revenue over the trailing twelve months, up 39.8% year over year.
- Is OptimizeRx profitable?
- OptimizeRx reported $6.8M in net income over the trailing twelve months, a 6.4% net margin.
- What are OptimizeRx's profit margins?
- Gross margin is 70.0% and operating margin is 13.2%, with a 6.4% net margin.
- What is OptimizeRx's earnings per share?
- OptimizeRx's diluted EPS over the trailing twelve months is $0.35.
- Where does OptimizeRx's income statement data come from?
- Every line is extracted from OptimizeRx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
